List of insiders holdings for ACADIA PHARMACEUTICALS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | BAKER BROS. ADVISORS LP 14159 L.P. 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 2026-02-26 18:59:24 | 43,294,373 0 | 43,294,373 | Form 13D |
| 2 | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 2026-06-02 16:32:44 | 205,752 39,448,603 | 39,654,355 | Form 4 |
| 3 | GORDON CARL L Director | 2005-04-22 17:16:41 | 0 1,485,512 | 1,485,512 | Form 4 |
| 4 | NOMURA INTERNATIONAL PLC Nomura Phase4 Ventures LTD Nomura Phase4 Ventures GP LTD Nomura Phase4 Ventures LP Member of 13G Group (1) 10% Owner | 2010-02-12 14:28:15 | 549,752 0 | 549,752 | Form 13G |
| 5 | Hacksell Uli CEO | 2015-02-19 17:58:47 | 313,500 115,549 | 429,049 | Form 4 |
| 6 | Brann Mark R President & CSO | 2006-06-19 16:23:17 | 52,593 317,756 | 370,349 | Form 4 |
| 7 | Williamson Douglas J Executive VP, Research & Dev | 2023-02-13 18:45:02 | 287,951 0 | 287,951 | Form 4 |
| 8 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | 2026-08-07 18:00:09 | 202,966 0 | 202,966 | Form 4 |
| 9 | DAVIS STEPHEN CEO | 2024-08-20 18:40:42 | 186,555 0 | 186,555 | Form 4 |
| 10 | Mills Roger EVP, DEVELOPMENT AND CMO | 2015-03-24 18:00:25 | 180,000 0 | 180,000 | Form 4 |
| 11 | GRAY MARY ANN Director | 2016-06-09 17:28:57 | 149,476 0 | 149,476 | Form 4 |
| 12 | Garner Thomas EVP, Chief Commercial Officer | 2026-03-10 18:00:13 | 126,440 0 | 126,440 | Form 4 |
| 13 | Richards Douglas E VP of Business Development | 2004-05-26 21:34:49 | 120,000 0 | 120,000 | Form 3 |
| 14 | Aasen Thomas H EXEC VP, CFO AND CBO | 2014-04-04 19:51:23 | 106,819 0 | 106,819 | Form 4 |
| 15 | Owen Adams Catherine Chief Executive Officer | 2026-03-26 20:00:15 | 85,333 0 | 85,333 | Form 4 |
| 16 | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 2024-11-19 20:43:42 | 81,931 0 | 81,931 | Form 4 |
| 17 | HARRIGAN EDMUND Director | 2026-06-01 18:00:18 | 68,463 0 | 68,463 | Form 4 |
| 18 | SOLAND DANIEL B Director | 2025-06-02 18:05:15 | 65,941 0 | 65,941 | Form 4 |
| 19 | Stankovic Srdjan R. President | 2022-11-22 16:34:37 | 61,234 0 | 61,234 | Form 4 |
| 20 | GAROFALO ELIZABETH A. Director | 2026-06-01 18:00:10 | 58,804 0 | 58,804 | Form 4 |
| 21 | Ndu Adora Director | 2026-06-01 18:00:14 | 58,223 0 | 58,223 | Form 4 |
| 22 | Thompson Elizabeth H.Z. EVP, Head of Research & Dev | 2026-07-31 18:00:17 | 51,266 0 | 51,266 | Form 4 |
| 23 | Brege Laura Director | 2026-06-01 18:00:13 | 48,517 0 | 48,517 | Form 4 |
| 24 | KIM AUSTIN D. EVP,General Counsel, Secretary | 2024-01-09 18:00:29 | 46,901 0 | 46,901 | Form 4 |
| 25 | WALTON ALAN G Director | 2009-06-16 16:22:08 | 44,722 0 | 44,722 | Form 4 |
| 26 | Kaiser John Joseph VP, Strat. Mrkting & Com. Dev. | 2008-10-22 19:38:07 | 40,000 0 | 40,000 | Form 4 |
| 27 | Daly James M Director | 2026-06-01 18:00:05 | 37,463 0 | 37,463 | Form 4 |
| 28 | Iversen Leslie L Director | 2016-04-20 17:37:28 | 36,127 0 | 36,127 | Form 4 |
| 29 | Tolf Bo-Ragnar VP/Mg. Dir. ACADIA Pharma AB | 2009-07-09 16:39:38 | 35,000 0 | 35,000 | Form 4 |
| 30 | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | 2026-03-26 20:00:12 | 33,827 0 | 33,827 | Form 4 |
| 31 | Moore Terrence O EVP, CHIEF COMMERCIAL OFFICER | 2017-03-10 20:37:19 | 33,750 0 | 33,750 | Form 4 |
| 32 | Davis Robert E Exec. VP, Drug Discovery | 2005-03-15 20:52:26 | 30,000 0 | 30,000 | Form 4 |
| 33 | Baity Glenn EVP AND GC | 2018-04-20 18:37:24 | 28,125 0 | 28,125 | Form 4 |
| 34 | Poole Jonathan Director | 2026-06-01 18:00:11 | 27,325 0 | 27,325 | Form 4 |
| 35 | YOUNG TODD S. EVP AND CFO | 2018-10-24 16:27:12 | 23,438 0 | 23,438 | Form 4 |
| 36 | Ridloff Elena EVP and CFO | 2021-04-30 18:55:12 | 17,044 0 | 17,044 | Form 4 |
| 37 | KAPLAN LESTER J PH D Director | 2015-08-13 17:10:12 | 17,000 0 | 17,000 | Form 4 |
| 38 | YANG MICHAEL J. EVP and CCO | 2021-01-08 19:31:12 | 16,226 0 | 16,226 | Form 4 |
| 39 | Lundstrom Brian Sr. VP, Bus. Development | 2008-03-11 20:06:11 | 16,000 0 | 16,000 | Form 4 |
| 40 | Kihara James PRINCIPAL ACCOUNTING OFFICER | 2026-06-29 18:00:05 | 13,088 0 | 13,088 | Form 4 |
| 41 | Wells William McDowall Director | 2015-06-17 19:11:56 | 12,500 0 | 12,500 | Form 4 |
| 42 | Rasmussen Torsten Director | 2015-06-17 19:10:36 | 0 12,500 | 12,500 | Form 4 |
| 43 | BORER MICHAEL T Director | 2015-06-17 19:06:59 | 12,500 0 | 12,500 | Form 4 |
| 44 | van Osch Martien Director | 2005-06-14 16:37:12 | 11,584 0 | 11,584 | Form 4 |
| 45 | Binder Gordon M Director | 2009-06-16 16:05:13 | 10,000 0 | 10,000 | Form 4 |
| 46 | Miller Eric Alejandro Controller & PAO | 2019-10-17 18:26:38 | 1,524 0 | 1,524 | Form 4 |
| 47 | Biggar Stephen R Director | 2013-01-23 16:41:51 | 0 0 | 0 | Form 3 |
| 48 | OXFORD BIOSCIENCE PARTNERS IV LP MRNA FUND II LP OBP MANAGEMENT IV LP BARNES JEFFREY T CARTHY MARK FLEMING JONATHAN LYTTON MICHAEL WALTON ALAN G 10% Owner | 2011-02-14 10:32:00 | 0 0 | 0 | Form 13G |